BHCM
NGVT icon

Brevan Howard Capital Management’s Ingevity NGVT Stock Holding History

Brevan Howard Capital Management’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$327K Sell
4,384
-7,137
-62% -$514K ﹤0.01% 1665
2026
Q1 		$821K Buy
+11,521
New +$788K 0.01% 1019
2025
Q4 		– Sell
-12,999
Closed -$717K – 2131
2025
Q3 		$717K Buy
+12,999
New +$676K ﹤0.01% 1087
2024
Q4 		– Sell
-19,160
Closed -$747K – 1304
2024
Q3 		$747K Buy
19,160
+10,116
+112% +$403K 0.01% 553
2024
Q2 		$395K Sell
9,044
-643
-7% -$31.1K ﹤0.01% 683
2024
Q1 		$462K Sell
9,687
-4,283
-31% -$193K ﹤0.01% 488
2023
Q4 		$660K Buy
13,970
+2,576
+23% +$107K 0.01% 375
2023
Q3 		$542K Buy
11,394
+3,210
+39% +$175K 0.01% 157
2023
Q2 		$476K Buy
+8,184
New +$491K 0.01% 138

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Brevan Howard Capital Management's NGVT Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Ingevity (NGVT) stake by 62% in Q2 2026, selling an estimated $514K and leaving 4,384 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Brevan Howard Capital Management first reported a position in NGVT in Q2 2023 and has held it in 9 quarters since. The position peaked at $821K in Q1 2026. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Brevan Howard Capital Management held 4,384 shares of Ingevity worth $327K as of Q2 2026.
  • Brevan Howard Capital Management sold 7,137 Ingevity shares in Q2 2026, an estimated $514K.
  • Ingevity made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1665 holding.
  • Brevan Howard Capital Management first reported a position in Ingevity in Q2 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Ingevity position peaked at $821K in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.